ENGLEWOOD, CO — (Marketwire) — 10/07/09 — Biomedical Technology Solutions Holdings, Inc. (“BMTS” or the “Company”; www.bmtscorp.com) (OTCBB: BMTL) is pleased to announce an agreement with Med Pro Associates of Colorado to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company’s Demolizer(R) II within the U.S.

Med Pro Associates, based in Idaho Springs, Colorado, is one of the nation’s largest independent representation firms specializing in the healthcare industry. They represent leading manufacturers in a sales support role through all distribution channels and market into the hospital, long term care and dental markets. The Med Pro team of highly qualified, professional field sales representatives provides national coverage and specializes in both medical equipment and disposable devices.

“Med Pro Associates is extremely excited about the addition of the BMTS line given the high profile and sensitivity to infection control and safety related products in today’s healthcare market. The Demolizer(R) II provides both a cost savings opportunity to the practitioner while responding to the demand of more environmentally friendly products,” states Manny Losada, President Med Pro Associates.

Under the terms of the agreement, Med Pro will market and sell BMTS’ Demolizer(R) II on a non-exclusive basis throughout the U.S. Don Cox, President and CEO of BMTS, said, “We are excited to have Med Pro representatives marketing the Demolizer(R) II extensively throughout the country. We continue to see great results with the Demolizer(R) II and have positive feedback from physicians, dentists, veterinarians and other care providers. Our customers continue to support this safe and environmentally friendly biomedical waste disposal device, and having the Med Pro team representing the Demolizer(R) II will increase our exposure and increase sales.”

About Biomedical Technology Solutions Holdings, Inc.

Biomedical Technology Solutions Holdings, Inc., located in Englewood, Colorado, sells the Demolizer(R) II through its wholly owned subsidiary Biomedical Technology Solutions, Inc. BMTS’ patented Demolizer(R) Technology converts infectious biomedical waste into non-infectious material. BMTS’ products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the US and a global market five times larger than the U.S. For more information, visit our investor relations page at www.bmtscorp.com.

About the Demolizer(R) II

The Demolizer(R) II is the GREEN alternative to biomedical waste disposal. The device is the only patented, portable, and self-contained system able to process both sharps and typical red bag biomedical waste onsite. The processed waste is rendered sterile and discarded as common trash eliminating up to 100% of the cost associated with its disposal. The Demolizer(R) II meets or exceeds all EPA and CDC guidelines and is approved or meets treatment requirements in 47 states after review by 78 governmental agencies. The device uses no chemicals or liquids, plugs into a normal outlet through a surge protector, and automatically records and prints state required documentation. The Demolizer(R) II provides a safer, more environmentally GREEN method for biomedical waste disposal.

Safe Harbor for Forward-Looking Statements

The statements contained in this press release may include certain projections and forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve a number of risks and uncertainties. Such statements reflect the Company’s current views with respect to future events and financial performance. No assurances can be given however, that these events will occur or that such expectations will be achieved and that actual results could differ materially from those described. Actual results of future operations of Biomedical Technology Solutions Holdings, Inc. may differ materially from those indicated by these forward-looking statements as a result of various important factors.

Contact:
Union Investor Relations
Ian Shanno
(310) 928-3780
is@unionir.com